Login / Signup

Multi-engineered Graphene Extended-Gate Field-Effect Transistor for Peroxynitrite Sensing in Alzheimer's Disease.

Qiwen PengQiankun ZengFangbing WangXiaoyuan WuRunxi ZhangGuoyue ShiMin Zhang
Published in: ACS nano (2023)
The expression of β-amyloid peptides (Aβ), a pathological indicator of Alzheimer's disease (AD), was reported to be inapparent in the early stage of AD. While peroxynitrite (ONOO - ) is produced excessively and emerges earlier than Aβ plaques in the progression of AD, it is thus significant to sensitively detect ONOO - for early diagnosis of AD and its pathological research. Herein, we unveiled an integrated sensor for monitoring ONOO - , which consisted of a commercially available field-effect transistor (FET) and a high-performance multi-engineered graphene extended-gate (EG) electrode. In the configuration of the presented EG electrode, laser-induced graphene (LIG) intercalated with MnO 2 nanoparticles (MnO 2 /LIG) can improve the electrical properties of LIG and the sensitivity of the sensor, and graphene oxide (GO)-MnO 2 /Hemin nanozyme with ONOO - isomerase activity can selectively trigger the isomerization of ONOO - to NO 3 - . With this synergistic effect, our EG-FET sensor can respond to the ONOO - with high sensitivity and selectivity. Moreover, taking advantage of our EG-FET sensor, we modularly assembled a portable sensing platform for wireless tracking ONOO - levels in the brain tissue of AD transgenic mice at earlier stages before massive Aβ plaques appeared, and we systematically explored the complex role of ONOO - in the occurrence and development of AD.
Keyphrases
  • early stage
  • carbon nanotubes
  • poor prognosis
  • cognitive decline
  • walled carbon nanotubes
  • room temperature
  • risk assessment
  • white matter
  • high throughput
  • radiation therapy
  • multiple sclerosis
  • rectal cancer